Clinical trial
A Phase IIA Trial of Two Schedules of Perifosine
NCT00389077 is registered in ClinicalTrials.gov with AEterna Zentaris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase IIA Trial of Two Schedules of Perifosine
- Lead sponsor
- AEterna Zentaris
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2005
- Completion date
- September 30, 2011
- Enrollment
- 558 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
lymphomas, tumors